13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in global, including the following market information:
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) companies in 2021 (%)
The global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serotype 6B Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) include Pfizer, Minhai Bio, Kexing Bio, Cansino Bio and Lanzhou Biological Preparations Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segment Percentages, by Type, 2021 (%)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segment Percentages, by Application, 2021 (%)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) revenues share in global market, 2021 (%)
Key companies 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) companies in 2021 (%)
The global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serotype 6B Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) include Pfizer, Minhai Bio, Kexing Bio, Cansino Bio and Lanzhou Biological Preparations Institute, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segment Percentages, by Type, 2021 (%)
- Serotype 6B
- 7F Serotype
- Serotype 9V
- 14 Serotype
- Serotype 18C
- Serotype 19A
- 19F Serotype
- 23F Serotype
- 24F Serotype
- Other
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segment Percentages, by Application, 2021 (%)
- Infants from 6 Weeks to 15 Months Old
- Children Aged 15 Months to 5 Years
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) revenues share in global market, 2021 (%)
Key companies 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Minhai Bio
- Kexing Bio
- Cansino Bio
- Lanzhou Biological Preparations Institute
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (PCV13) OVERALL MARKET SIZE
2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size: 2021 VS 2028
2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market
3.2 Top Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies Ranked by Revenue
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Companies
3.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Companies
3.5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
3.8 Tier 1, Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market
3.8.1 List of Global Tier 1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies
3.8.2 List of Global Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Markets, 2021 & 2028
4.1.2 Serotype 6B
4.1.3 7F Serotype
4.1.4 Serotype 9V
4.1.5 14 Serotype
4.1.6 Serotype 18C
4.1.7 Serotype 19A
4.1.8 19F Serotype
4.1.9 23F Serotype
4.1.10 24F Serotype
4.1.11 Other
4.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
4.2.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2022
4.2.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2023-2028
4.2.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
4.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
4.3.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2022
4.3.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2023-2028
4.3.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
4.4 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2021 & 2028
5.1.2 Infants from 6 Weeks to 15 Months Old
5.1.3 Children Aged 15 Months to 5 Years
5.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
5.2.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2022
5.2.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2023-2028
5.2.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
5.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
5.3.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2022
5.3.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2023-2028
5.3.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
5.4 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2021 & 2028
6.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
6.2.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2022
6.2.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2023-2028
6.2.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
6.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
6.3.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2022
6.3.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2023-2028
6.3.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.4.2 By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.4.3 US 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.4.4 Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.4.5 Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.5.2 By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.5.3 Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.4 France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.5 U.K. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.6 Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.7 Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.8 Nordic Countries 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.9 Benelux 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.6.2 By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.6.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6.4 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6.5 South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6.6 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6.7 India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.7.2 By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.7.3 Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.7.4 Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.8.3 Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.8.4 Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.8.5 Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.8.6 UAE 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Minhai Bio
7.2.1 Minhai Bio Corporate Summary
7.2.2 Minhai Bio Business Overview
7.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.2.5 Minhai Bio Key News
7.3 Kexing Bio
7.3.1 Kexing Bio Corporate Summary
7.3.2 Kexing Bio Business Overview
7.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.3.5 Kexing Bio Key News
7.4 Cansino Bio
7.4.1 Cansino Bio Corporate Summary
7.4.2 Cansino Bio Business Overview
7.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.4.5 Cansino Bio Key News
7.5 Lanzhou Biological Preparations Institute
7.5.1 Lanzhou Biological Preparations Institute Corporate Summary
7.5.2 Lanzhou Biological Preparations Institute Business Overview
7.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.5.5 Lanzhou Biological Preparations Institute Key News
8 GLOBAL 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (PCV13) PRODUCTION CAPACITY, ANALYSIS
8.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, 2017-2028
8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity of Key Manufacturers in Global Market
8.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (PCV13) SUPPLY CHAIN ANALYSIS
10.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Value Chain
10.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Upstream Market
10.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (PCV13) OVERALL MARKET SIZE
2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size: 2021 VS 2028
2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market
3.2 Top Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies Ranked by Revenue
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Companies
3.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Companies
3.5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
3.8 Tier 1, Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market
3.8.1 List of Global Tier 1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies
3.8.2 List of Global Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Markets, 2021 & 2028
4.1.2 Serotype 6B
4.1.3 7F Serotype
4.1.4 Serotype 9V
4.1.5 14 Serotype
4.1.6 Serotype 18C
4.1.7 Serotype 19A
4.1.8 19F Serotype
4.1.9 23F Serotype
4.1.10 24F Serotype
4.1.11 Other
4.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
4.2.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2022
4.2.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2023-2028
4.2.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
4.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
4.3.1 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2022
4.3.2 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2023-2028
4.3.3 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
4.4 By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2021 & 2028
5.1.2 Infants from 6 Weeks to 15 Months Old
5.1.3 Children Aged 15 Months to 5 Years
5.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
5.2.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2022
5.2.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2023-2028
5.2.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
5.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
5.3.1 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2022
5.3.2 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2023-2028
5.3.3 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
5.4 By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2021 & 2028
6.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue & Forecasts
6.2.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2022
6.2.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2023-2028
6.2.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
6.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales & Forecasts
6.3.1 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2022
6.3.2 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2023-2028
6.3.3 By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.4.2 By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.4.3 US 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.4.4 Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.4.5 Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.5.2 By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.5.3 Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.4 France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.5 U.K. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.6 Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.7 Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.8 Nordic Countries 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.5.9 Benelux 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.6.2 By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.6.3 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6.4 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6.5 South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6.6 Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.6.7 India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.7.2 By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.7.3 Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.7.4 Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, 2017-2028
6.8.3 Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.8.4 Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.8.5 Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
6.8.6 UAE 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Minhai Bio
7.2.1 Minhai Bio Corporate Summary
7.2.2 Minhai Bio Business Overview
7.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.2.5 Minhai Bio Key News
7.3 Kexing Bio
7.3.1 Kexing Bio Corporate Summary
7.3.2 Kexing Bio Business Overview
7.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.3.5 Kexing Bio Key News
7.4 Cansino Bio
7.4.1 Cansino Bio Corporate Summary
7.4.2 Cansino Bio Business Overview
7.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.4.5 Cansino Bio Key News
7.5 Lanzhou Biological Preparations Institute
7.5.1 Lanzhou Biological Preparations Institute Corporate Summary
7.5.2 Lanzhou Biological Preparations Institute Business Overview
7.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Major Product Offerings
7.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales and Revenue in Global (2017-2022)
7.5.5 Lanzhou Biological Preparations Institute Key News
8 GLOBAL 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (PCV13) PRODUCTION CAPACITY, ANALYSIS
8.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity, 2017-2028
8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity of Key Manufacturers in Global Market
8.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (PCV13) SUPPLY CHAIN ANALYSIS
10.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Value Chain
10.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Upstream Market
10.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in Global Market
Table 2. Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Companies, 2017-2022
Table 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Companies, (K Units), 2017-2022
Table 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
Table 9. List of Global Tier 1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2017-2022
Table 15. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2023-2028
Table 16. By Application – Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2017-2022
Table 20. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2023-2028
Table 21. By Region – Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2017-2022
Table 25. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2023-2028
Table 26. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 29. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 30. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 33. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 34. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 37. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 38. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 41. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 48. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Minhai Bio Corporate Summary
Table 50. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 51. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Kexing Bio Corporate Summary
Table 53. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 54. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Cansino Bio Corporate Summary
Table 56. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 57. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Lanzhou Biological Preparations Institute Corporate Summary
Table 59. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 60. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region, 2017-2022 (K Units)
Table 64. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region, 2023-2028 (K Units)
Table 65. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Opportunities & Trends in Global Market
Table 66. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers in Global Market
Table 67. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints in Global Market
Table 68. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Raw Materials
Table 69. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Raw Materials Suppliers in Global Market
Table 70. Typical 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream
Table 71. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream Clients in Global Market
Table 72. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors and Sales Agents in Global Market
Table 1. Key Players of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) in Global Market
Table 2. Top 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Share by Companies, 2017-2022
Table 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Companies, (K Units), 2017-2022
Table 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Type
Table 9. List of Global Tier 1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2017-2022
Table 15. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2023-2028
Table 16. By Application – Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2017-2022
Table 20. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2023-2028
Table 21. By Region – Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2017-2022
Table 25. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), 2023-2028
Table 26. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 29. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 30. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 33. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 34. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 37. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 38. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 41. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 48. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Minhai Bio Corporate Summary
Table 50. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 51. Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Kexing Bio Corporate Summary
Table 53. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 54. Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Cansino Bio Corporate Summary
Table 56. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 57. Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Lanzhou Biological Preparations Institute Corporate Summary
Table 59. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Offerings
Table 60. Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region, 2017-2022 (K Units)
Table 64. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production by Region, 2023-2028 (K Units)
Table 65. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Opportunities & Trends in Global Market
Table 66. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Drivers in Global Market
Table 67. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints in Global Market
Table 68. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Raw Materials
Table 69. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Raw Materials Suppliers in Global Market
Table 70. Typical 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream
Table 71. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream Clients in Global Market
Table 72. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type
Figure 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
Figure 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028 (US$, Mn)
Figure 7. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue in 2021
Figure 9. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 10. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 11. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 13. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 14. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 16. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 17. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 18. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 19. US 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 24. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 25. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 33. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 37. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 39. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 40. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 44. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 48. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region, 2021 VS 2028
Figure 50. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type
Figure 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
Figure 3. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, 2017-2028 (US$, Mn)
Figure 7. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue in 2021
Figure 9. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 10. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 11. By Type - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 13. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 14. By Application - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 16. By Region - Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 17. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 18. By Country - North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 19. US 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 24. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 25. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 33. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 37. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 39. By Country - South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 40. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share, 2017-2028
Figure 44. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue, (US$, Mn), 2017-2028
Figure 48. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region, 2021 VS 2028
Figure 50. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Value Chain
Figure 51. Marketing Channels
